Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioblastoma × Injections × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 11 Recurrence 3 Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 3 Neoplasm Metastasis 2 Lymphoma, B-Cell 2 Leukemia, Monocytic, Acute 2 Breast Neoplasms 2 Advanced Solid Tumors 2 Solid Tumor 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Non-Squamous Non-small Cell Lung Cancer 1 Nasopharyngeal Carcinoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Microsatellite Instability 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Basophilic, Acute 1 Leukemia 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1

Interventions

Temozolomide 38 Radiotherapy 16 Radiation 11 Nivolumab 9 Magnetic Resonance Spectroscopy 9 Specimen Handling 7 pembrolizumab 6 Bevacizumab 6 atezolizumab 4 Lomustine 4 olaparib 3 Photons 3 Ipilimumab 3 Immunoglobulin G 3 Disulfides 3 Diet, Ketogenic 3 Cyclophosphamide 3 trametinib 2 sargramostim 2 poly ICLC 2 pamiparib 2 niraparib 2 dabrafenib 2 azeliragon 2 Transurethral Resection of Bladder 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Standard of Care 2 Receptors, Interleukin-8B 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04808245 2025-09-22

INTERCEPT-H3

German Cancer Research Center

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡